United States · 
What does Windamere Venture Partners invest in?
Windamere Venture Partners invests most often at Series A and Series B (71% of the rounds on record).
Windamere Venture Partners highlights
- 01
7 rounds on record
- 02
Mostly Series A and Series B: 71% of its rounds
- 03
4 exits from the portfolio
What they do
- Type
- VC firm (from a list, unverified)
- Cheque size
- Not stated
- Based in
- United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first7 appearances
- 2008
1 round
- Feb
- 2007
1 round
- Jan
- 2005
1 round
- Jun
- 2004
2 rounds
- Aug
- Jun
- 2003
1 round
- May
- 2002
1 round
- Dec
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
We hold 2 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
Exits from the portfolio
Companies it backed that were later bought or listed4 in all
SantarusBought by Salix Pharmaceuticals$2.6BNov 2013
Somaxon PharmaceuticalsBought by Pernix TherapeuticsUndisclosedMar 2013
SkinMedicaBought by AllerganUndisclosedNov 2012
SantarusListedUndisclosedApr 2004
An exit counts when it came after the firm's first round in the company. From historical deal records.